Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes

已完结 10 由 wu2025 发布于 2025/12/22 14:44:40

DOI:10.1038/s41586-025-10031-z
作者：Lixin Guo, Bo Zhang, Xia Xue, Xin Zhang, Hanqing Cai, Hongwei Jiang, Lili Zhang, Ping Jin, Xiaojing Wang, Zhifeng Cheng, Suhe Zhang, Jianlin Geng, Yushan Guo, Hanbo Hu, Qingyang Ma, Li Li, Haiwei Du,
文献类型：期刊论文
补充材料：只需要正文

Nature

Abstract：Mazdutide is a once-weekly glucagon and glucagon-like peptide-1 receptor dual agonist developed for the treatment of type 2 diabetes (T2D) 1. This study assessed the efficacy and safety of m

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierConvective heat transfer modelling in dry-running polymer spur gears